SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001372514-23-000010
Filing Date
2023-02-07
Accepted
2023-02-07 07:01:56
Documents
13
Period of Report
2023-02-07
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K kprx-20230207.htm   iXBRL 8-K 33851
2 EX-99.1 ex991-pressreleasekiox101p.htm EX-99.1 10905
  Complete submission text file 0001372514-23-000010.txt   188331

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT kprx-20230207.xsd EX-101.SCH 1917
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT kprx-20230207_lab.xml EX-101.LAB 24849
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT kprx-20230207_pre.xml EX-101.PRE 13056
7 EXTRACTED XBRL INSTANCE DOCUMENT kprx-20230207_htm.xml XML 11187
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36672 | Film No.: 23592746
SIC: 2834 Pharmaceutical Preparations